Physician profile
Ryan Ellsworth
NPI 1104130574
$4,615.00
in general payments reported to CMS, 2019-2025
24 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 94% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $928 · 2021: $226 · 2022: $13.51 · 2023: $124 · 2024: $105 · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Food and Beverage | $515.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $1,800.00 | 2025 | Magnetos |
| Treace Medical Concepts, INC. | $1,093.64 | 2019-2020 | |
| Stryker Corporation | $685.10 | 2019-2020 | |
| Flower Orthopedics Coporation | $200.45 | 2025 | |
| Anika Therapeutics, INC. | $181.17 | 2021-2023 | Arthrosurface Hammertoes, Tactoset |
| Horizon Therapeutics Plc | $143.26 | 2020-2023 | Krystexxa |
| Organogenesis INC. | $117.73 | 2019 | |
| Abbvie INC. | $65.83 | 2023-2024 | |
| Medtronic, INC. | $39.77 | 2024-2025 | Biomedicus |
| Averitas Pharma INC. | $35.87 | 2023 | Qutenza |
| Valencia Technologies Corporation | $30.29 | 2025 | Ecoin Device Kit |
| Zyla Life Sciences, INC. | $28.95 | 2020 | |
| Triad Life Sciences INC. | $25.85 | 2021 | |
| Nevro Corp. | $23.33 | 2023 | Senza |
| Mckesson Medical-Surgical, INC. | $22.01 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $19.75 | 2025 | Physio-Stim |
| Allergan, INC. | $18.55 | 2020 | |
| Solventum Corporation | $17.10 | 2024 | Snap, Activ.A.C. |
| Mimedx Group, INC. | $14.86 | 2025 | |
| Smith+Nephew, INC. | $13.51 | 2022 | |
| Kci USA, INC. | $12.85 | 2020 | |
| Rikco International, LLC | $12.62 | 2019 | |
| Wright Medical Technology, INC. | $12.51 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Ellsworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.